Spotlight on the News

IMS Developing Advanced Monitoring Platform

Integrated Medical Sensors (IMS) (https://integratedmedicalsensors.com), a medical device company, is developing innovative monitoring tools to transform how chronic diseases such as diabetes can be better monitored and managed.

To do this, IMS is collaborating with the Juvenile Diabetes Research foundation (JDRF), (https://www.jdrf.org) a leading T1D research organization that has invested more than $2.5 billion in research funding since their inception.

The award from JDRF supports IMS's focus on developing continuous diabetes monitoring devices to monitor glucose, ketones, lactate, and other analytes using a single multiplexing sensor applied via traditional transdermal applicator technology.

The technology enables a single hair thin sensor to provide multi-analyte continuous diabetes monitoring. The IMS device is easy to apply and wear, and enables holistic metabolic control. In addition to funding JDRF is also contributing strategic support through their expertise and vast network in the diabetes field.

According to Jonathan Rosen, PhD, JDRF's Director of Research, "Diabetic ketoacidosis remains a critical risk for people with type one diabetes. IMS's continuous glucose and ketone monitoring technology has the potential to help prevent this dangerous acute complication by letting people know when their ketones are rising so they can take preventive action."

Muhammad Mujeeb-U-Rahman, CEO, IMS points out, "This collaboration will help advance our cutting-edge continuous diabetes monitoring program, enable us to advance past our current glucose-only human clinical trials, and bring us closer to multianalyte human clinical studies."